Literature DB >> 8781748

Alterations in mitochondrial DNA and enzyme activities in hypertrophied myocardium of stroke-prone SHRS.

T Tokoro1, H Ito, T Suzuki.   

Abstract

To clarify the pathophysiological alteration of mitochondria in SHRSP hypertrophied heart, mitochondria-related enzyme changes were examined and compared to those in WKY. Furthermore, the structure alteration in mitochondrial DNA (mtDNA) was examined by restriction fragment length polymorphisms (RFLPs). Both isocitrate dehydrogenase (ICDH) and cytochrome c oxidase (COX), which are related to energy production or the respiratory chain in mitochondria, were significantly lower in SHRSP myocardium than in WKY. Furthermore, superoxide dismutase (SOD), a potent radical scavenger, was also lower in SHRSP myocardium. RFLPs analysis by Rsa I revealed two deletions in the electrophoretic band in the SHRSP myocardium, but not in the liver. These findings suggest that mitochondrial dysfunction, especially lower energy production, could be an important factor for the pathogenesis of further myocardial degeneration. The results also suggest that mitochondrial alterations, in the membrane system as well as mtDNA, may be caused by oxidative stress in mitochondria because of decreased scavenging activity.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8781748     DOI: 10.3109/10641969609081769

Source DB:  PubMed          Journal:  Clin Exp Hypertens        ISSN: 1064-1963            Impact factor:   1.749


  2 in total

Review 1.  Mitochondrial Dysfunction Contributes to Hypertensive Target Organ Damage: Lessons from an Animal Model of Human Disease.

Authors:  Speranza Rubattu; Rosita Stanzione; Massimo Volpe
Journal:  Oxid Med Cell Longev       Date:  2016-08-09       Impact factor: 6.543

2.  Myocardial adaptation of energy metabolism to elevated preload depends on calcineurin activity : a proteomic approach.

Authors:  Peter Schott; Abdul R Asif; Christopher Gräf; Karl Toischer; Gerd Hasenfuss; Harald Kögler
Journal:  Basic Res Cardiol       Date:  2008-02-15       Impact factor: 17.165

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.